상세불명의 비대상성 간경변증 환자 치험 1례
A Case Report of a Patient Diagnosed with Decompensated Liver Cirrhosis due to Unspecified Causes
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study aimed to describe whether Saenggangunbi-tang supports clinical management of a patient with decompensated liver cirrhosis without unfavorable side effects. Methods: A 78-year-old woman diagnosed with unspecified liver cirrhosis in 2014, who had undergone abdominal paracentesis twice until 2014 and variceal ligation twice until 2017, took Saenggangunbi-tang from July 25, 2019 to March 23, 2020. We observed clinical changes, such as fatigue, leg edema, and gingival bleeding, as well as laboratory findings. Results: After taking Saenggangunbi-tang for about eight months, the patient’s symptoms and serum levels of liver enzymes were improved in comparison to her symptoms and serum levels at the first visit. Moreover, there was no occurrence of any complications, such as ascites and gastroesophageal variceal bleeding by portal hypertension. Conclusions: This study suggests that Saenggangunbi-tang might be effective in the treatment of decompensated liver cirrhosis.
Abstract
Objectives: This study aimed to describe whether Saenggangunbi-tang supports clinical management of a patient with decompensated liver cirrhosis without unfavorable side effects. Methods: A 78-year-old woman diagnosed with unspecified liver cirrhosis in 2014, who had undergone abdominal paracentesis twice until 2014 and variceal ligation twice until 2017, took Saenggangunbi-tang from July 25, 2019 to March 23, 2020. We observed clinical changes, such as fatigue, leg edema, and gingival bleeding, as well as laboratory findings. Results: After taking Saenggangunbi-tang for about eight months, the patient’s symptoms and serum levels of liver enzymes were improved in comparison to her symptoms and serum levels at the first visit. Moreover, there was no occurrence of any complications, such as ascites and gastroesophageal variceal bleeding by portal hypertension. Conclusions: This study suggests that Saenggangunbi-tang might be effective in the treatment of decompensated liver cirrhosis.
참고문헌 (19)
- Chung W, "The cost of liver disease in Korea:methodology, data, and evidence", Clin Mol Hepatol, 21(1), pp.14~21 (2015)
- European Association for the Study of the Liver, "EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis", J Hepatol, 69(2), pp.406~460 (2018)
- Cho EJ, "Relative Etiological Role of Prior Hepatitis B Virus Infection and Nonalcoholic Fatty Liver Disease in the Development of Non-B Non-C Hepatocellular Carcinoma in a Hepatitis B-Endemic Area", Digestion, 84(suppl 1), pp.17~22 (2011)
- Jihye Kim, "Potential etiology, prevalence of cirrhosis, and mode of detection among patients with non-B non-C hepatocellular carcinoma in Korea", The Korean Journal of Internal Medicine, 35(1), pp.65~78 (2020), 대한내과학회[DOI]
- D'Amico G, "Natural history and prognostic indicators of survival in cirrhosis : a systematic review of 118 studies", J Hepatol, 44(1), pp.217~231 (2006)
- Suk KT, "Revision and update on clinical practice guideline for liver cirrhosis", Korean J Hepatol, 18(1), pp.1~21 (2012)
- Lonardo A, "Hypertension, diabetes, atherosclerosis and NASH:Cause or consequence?", J Hepatol, 68(2), pp.335~352 (2018)
- Poonawala A, "Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis:a case-control study", Hepatology, 32(4), pp.689~692 (2000)
- Liu TL, "Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis", Dig Dis Sci, 61(11), pp.3335~3345 (2016)
- Umetsu S, "Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation", Sci Rep, 10(1), pp.1156~ (2020)
- 박수영, "임상적으로 간경변증의 증후가 없는 만성 B형 간염에서 간섬유화의 지표로서 AST", ALT 비와 혈소판 수치의 임상적 유용성, 2004, pp.43(4), 246~251[DOI]
- Goff JS, "Three years experience with endoscopic variceal ligation for treatment of bleeding varices", Endoscopy, 24(5), pp.401~404 (1992)
- Seo YH, "Case Report of Suggested Alcoholic Hepatitis Treated with Saenggangeonbi-tang and Kongjin-Dan", The Journal of East-West Medicine, 36(4), pp.83~89 (2011)
- Lee IW, "Saeng-Kankunbi-Tang protects liver against oxidative damage through activation of ERK", Nrf2 pathway, 2016, pp.22(8), 619~628
- 김재용, "生肝健脾湯이 HepG2 cell의 증식, 세포사멸 및 활성조절 신호전달계에 미치는 영향", 대한한방내과학회지, 27(1), pp.149~165 (2006), 대한한방내과학회
- 이은, "生肝健脾湯加三七根이 흰쥐의 간섬유화 억제에 미치는 영향", 대한한방내과학회지, 29(2), pp.500~511 (2008), 대한한방내과학회
- Li F, "The Clinical Study of Cirrhosis Abdominal Dropsy with Combined Chinese Medicine and Western Medicine", Journal of Henan University of Chinese Medicine, (5), pp.37~38 (2007)
- Zhou HP, "Clinical study of liver cirrhosis treated by integrated traditional Chinese and western medicine", Chin J Integr Tradit Western Med, 21(4), pp.199~201 (2013)
- Kim J, "A Case Report of ascites in Liver cirrhosis treated with Saenggangeonbi-tang", J Int Korean Med, (spr), pp.299~305 (2010)